2021
DOI: 10.1038/s41536-021-00158-8
|View full text |Cite
|
Sign up to set email alerts
|

Personalized medicine for reconstruction of critical-size bone defects – a translational approach with customizable vascularized bone tissue

Abstract: Tissue engineering principles allow the generation of functional tissues for biomedical applications. Reconstruction of large-scale bone defects with tissue-engineered bone has still not entered the clinical routine. In the present study, a bone substitute in combination with mesenchymal stem cells (MSC) and endothelial progenitor cells (EPC) with or without growth factors BMP-2 and VEGF-A was prevascularized by an arteriovenous (AV) loop and transplanted into a critical-size tibia defect in the sheep model. W… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 46 publications
0
23
0
1
Order By: Relevance
“…In the latter case, matrix-encapsulated, proliferating producer cells should be injected or implanted locally for long-term production of a biological directly at the target tissue of interest . In this concept, an appropriate pre-vascularization is helpful for clinical translation to maintain sufficient vascularity of any therapeutic constructs . Furthermore, another crucial factor for therapeutic protein delivery is the used cell type, as stable protein expression, successful scale-up, and long-term production should be guaranteed. , …”
Section: Introductionmentioning
confidence: 99%
“…In the latter case, matrix-encapsulated, proliferating producer cells should be injected or implanted locally for long-term production of a biological directly at the target tissue of interest . In this concept, an appropriate pre-vascularization is helpful for clinical translation to maintain sufficient vascularity of any therapeutic constructs . Furthermore, another crucial factor for therapeutic protein delivery is the used cell type, as stable protein expression, successful scale-up, and long-term production should be guaranteed. , …”
Section: Introductionmentioning
confidence: 99%
“…In this study, CM from a human ADSC cell line was used. Patient-dependent individual factors, such as high age, adiposity, comorbidities, or possible treatments could have a negative effect on ADSC's regenerative potential to grow and differentiate and therefore on their secretome [10,[39][40][41][42]. There still is the need for further experiments with ADSCs from different patients to analyze their interindividual differences, their impact on ADSC behavior [43,44], and, in a next step, their influence on wound healing.…”
Section: Discussionmentioning
confidence: 99%
“…This field has advanced greatly in recent years. New advanced technologies of bioadditive manufacturing allow the construction of structures closer in architecture to bone tissue [24]. However, many of the biogels used to create 3D cultures contain substances that are not approved for clinical use.…”
Section: Discussionmentioning
confidence: 99%